Monthly shot could replace daily pills for mental health
NCT ID NCT07185815
Summary
This study is testing a new monthly injection of a medication called cariprazine for people with schizophrenia, bipolar disorder, or major depression. It aims to see if the injection is safe, how the body processes it, and if it helps control symptoms. The study will enroll 24 adults who are currently stable on other medications but could benefit from switching to cariprazine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Research Center
RECRUITINGNess Ziona, 741000, Israel
Contact
-
Israeli Medical Center for Alzheimer
RECRUITINGRamat Gan, 56621, Israel
Contact
-
Tel Aviv, Israel
RECRUITINGTel Aviv, 6423906, Israel
Contact
Conditions
Explore the condition pages connected to this study.